Navigation Links
Reality Coalition applauds FDA
Date:12/23/2008

NEW YORK, December 23, 2008 The Reality Coalition a group of experts and organizations on overweight and obesity applauds the U.S. Food and Drug Administration's (FDA) efforts to recall and warn consumers about dietary supplements that claim to provide weight loss and contain undeclared, active pharmaceutical ingredients.

The FDA's efforts align with the mission of the Reality Coalition to increase consumer education and understanding of sound weight loss principles and reinforce realistic approaches to weight loss.

"Consumers should avoid dietary weight loss products that pose serious health risks," said Reality Coalition co-chair George L. Blackburn, MD, Ph.D. "To the best of my knowledge, identifying 25 tainted weight loss products is the largest action by the FDA."

"We have always argued that weight loss supplements are not effective and unregulated, and now that these products have been shown to contain undeclared ingredients and may endanger health, this action by the FDA is of great urgency," said Reality Coalition co-chair MRC Greenwood, Ph.D. "Dietary supplements that claim to provide weight loss make false promises, perpetuating the belief that there are quick fixes, which is inaccurate and unsafe. To have a lasting effect, weight loss should be gradual and based on modifications to diet and exercise."


'/>"/>

Contact: Dave Schemelia
dschemelia@healthstarpr.com
609-468-9325
HealthStar PR
Source:Eurekalert

Page: 1

Related medicine news :

1. Brand New Reality Series Follows the Emotional Journey of Five Friends as They Attempt to Go From Fat to Fit on DietTribe Premiering January 5th on Lifetime Television
2. Ground-breaking New Reality Show Hair Loss Confidential Launches First Webisode
3. Decision Resources White Paper Discusses Increasing Reality of Biosimilars and their Impact on Biologics Market
4. Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging
5. Veterinary Pet Insurance Reports Pet Emergencies a Costly Reality
6. E-prescribing of Controlled Substances Moves Real-Time Prescription Drug Monitoring Toward Reality
7. The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The Ns Student Body
8. Virtual Reality Therapy May Help PTSD Patients
9. Restaurant inspections -- public perceptions vs. reality
10. New Report Reveals Students Lack Awareness of Resources Needed by Pregnant and Parenting College Students: Perception is Reality
11. VisionFirst to Create Birminghams Next Reality Star with Beyond the Big E Contest
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3Gene Data Tool Advances Prospects for Personalized Medicine 59221 1Gene Data Tool Advances Prospects for Personalized Medicine 59221 2Gene Data Tool Advances Prospects for Personalized Medicine 59221 3Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 1Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 2Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 3